<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39200127</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>25</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19 Pain Is Not Associated with DNA Methylation Levels of the <i>ACE2</i> Promoter in COVID-19 Survivors Hospitalized Due to SARS-CoV-2 Infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1662</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines12081662</ELocationID><Abstract><AbstractText>One of theories explaining the development of long-lasting symptoms after an acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection include changes in the methylation pattern of the host. The current study aimed to investigate whether DNA methylation levels associated with the angiotensin-converting enzyme 2 (<i>ACE2</i>) promoter are different when comparing individuals previously hospitalized due to COVID-19 who then developed long-lasting post-COVID pain with those previously hospitalized due to COVID-19 who did not develop post-COVID-19 pain symptoms. Non-stimulated saliva samples were obtained from a cohort of 279 (mean age: 56.5, SD: 13.0 years old, 51.5% male) COVID-19 survivors who needed hospitalization. Clinical data were collected from hospital medical records. Participants were asked to disclose pain symptoms developed during the first three months after hospital admission due to COVID-19 and persisting at the time of the interview. Methylations of five CpG dinucleotides in the <i>ACE2</i> promoter were quantified (as percentages). Participants were evaluated up to 17.8 (SD: 5.3) months after hospitalization. Thus, 39.1% of patients exhibited post-COVID-19 pain. Most patients (77.05%) in the cohort developed localized post-COVID-19 pain. Headache and pain in the lower extremity were experienced by 29.4% of the patients. Seven patients received a post-infection diagnosis of fibromyalgia based on the presence of widespread pain characteristics (11.6%) and other associated symptoms. No significant differences in methylation percentages at any CpG location of the <i>ACE2</i> promoter were identified when comparing individuals with and without post-COVID-19 pain. The current study did not observe differences in methylation levels of the <i>ACE2</i> promoter depending on the presence or absence of long-lasting post-COVID-19 pain symptoms in individuals who needed hospitalization due to COVID-19 during the first wave of the pandemic.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-de-Las-Pe&#xf1;as</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3772-9690</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos (URJC), 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), Sensory Motor Interaction (SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xed;az-Gil</LastName><ForeName>Gema</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3480-1490</Identifier><AffiliationInfo><Affiliation>Research Group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), 28933 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gil-Crujera</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1022-5831</Identifier><AffiliationInfo><Affiliation>Research Group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), 28933 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-S&#xe1;nchez</LastName><ForeName>Stella M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0002-7140-4286</Identifier><AffiliationInfo><Affiliation>Research Group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), 28933 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambite-Quesada</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6755-8189</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos (URJC), 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franco-Moreno</LastName><ForeName>Anabel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan-Murua</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4212-7419</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Macho</LastName><ForeName>Juan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3357-4038</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellicer-Valero</LastName><ForeName>Oscar J</ForeName><Initials>OJ</Initials><Identifier Source="ORCID">0000-0002-0104-1029</Identifier><AffiliationInfo><Affiliation>Image Processing Laboratory (IPL), Universitat de Val&#xe8;ncia, Parc Cient&#xed;fic, 46980 Paterna, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arendt-Nielsen</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), Sensory Motor Interaction (SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterology &amp; Hepatology, Mech-Sense, Clinical Institute, Aalborg University Hospital, DK-9000 Aalborg, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Steno Diabetes Center North Denmark, Clinical Institute, Aalborg University Hospital, DK-9000 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giordano</LastName><ForeName>Rocco</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1331-129X</Identifier><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), Sensory Motor Interaction (SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery, Aalborg University Hospital, DK-9000 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>LONG-COVID-EXP-CM</GrantID><Agency>Comunidad de Madrid</Agency><Country/></Grant><Grant><GrantID>NNF21OC0067235</GrantID><Agency>Novo Nordisk Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">methylation</Keyword><Keyword MajorTopicYN="N">pain</Keyword><Keyword MajorTopicYN="N">post-COVID-19</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>29</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39200127</ArticleId><ArticleId IdType="pmc">PMC11351822</ArticleId><ArticleId IdType="doi">10.3390/biomedicines12081662</ArticleId><ArticleId IdType="pii">biomedicines12081662</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akbarialiabad H., Taghrir M.H., Abdollahi A., Ghahramani N., Kumar M., Paydar S., Razani B., Mwangi J., Asadi-Pooya A.A., Malekmakan L., et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49:1163&#x2013;1186. doi: 10.1007/s15010-021-01666-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01666-x</ArticleId><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global prevalence of post COVID-19 condition or long COVID: A meta-analysis and systematic review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-term sequelae of COVID-19: A systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022;11:269. doi: 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Notarte K.I., Macasaet R., Velasco J.V., Catahay J.A., Therese Ver A., Chung W., Valera-Calero J.A., Navarro-Santana M. Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: A systematic review and meta-analysis. J. Infect. 2024;88:77&#x2013;88. doi: 10.1016/j.jinf.2023.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2023.12.004</ArticleId><ArticleId IdType="pubmed">38101521</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati M., Udeh R., Yon D.K., Lee S.W., Dolja-Gore X., McEVoy M., Kenna T., Jacob L., L&#xf3;pez S&#xe1;nchez G.F., Koyanagi A., et al. A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences. J. Med. Virol. 2023;95:e28852. doi: 10.1002/jmv.28852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28852</ArticleId><ArticleId IdType="pubmed">37288652</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Navarro-Santana M., Plaza-Manzano G., Palacios-Ce&#xf1;a D., Arendt-Nielsen L. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived to SARS-CoV-2 infection: A systematic review and meta-analysis. Pain. 2022;163:1220&#x2013;1231. doi: 10.1097/j.pain.0000000000002496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002496</ArticleId><ArticleId IdType="pubmed">34561390</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerzhner O., Berla E., Har-Even M., Ratmansky M., Goor-Aryeh I. Consistency of inconsistency in long-COVID-19 pain symptoms persistency: A systematic review and meta-analysis. Pain Pract. 2024;24:120&#x2013;159. doi: 10.1111/papr.13277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/papr.13277</ArticleId><ArticleId IdType="pubmed">37475709</ArticleId></ArticleIdList></Reference><Reference><Citation>Bak&#x131;lan F., G&#xf6;kmen &#x130;.G., Ortanca B., U&#xe7;an A., Eker G&#xfc;ven&#xe7; &#x15e;., &#x15e;ahin Mutlu F., G&#xf6;kmen H.M., Ekim A. Musculoskeletal symptoms and related factors in postacute COVID-19 patients. Int. J. Clin. Pract. 2021;75:e14734. doi: 10.1111/ijcp.14734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14734</ArticleId><ArticleId IdType="pmc">PMC8420386</ArticleId><ArticleId IdType="pubmed">34387911</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F., Demircio&#x11f;lu G.F., Karde&#x15f; S. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: Prospective follow-up by phone interviews. Rheumatol. Int. 2021;41:1263&#x2013;1271. doi: 10.1007/s00296-021-04882-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04882-8</ArticleId><ArticleId IdType="pmc">PMC8114015</ArticleId><ArticleId IdType="pubmed">33978818</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares F.H.C., Kubota G.T., Fernandes A.M., Hojo B., Couras C., Costa B.V., Lapa J.D.D.S., Braga L.M., Almeida M.M., Cunha P.H.M.D., et al. &#x201c;Pain in the Pandemic Initiative Collaborators&#x201d;. Prevalence and characteristics of new-onset pain in COVID-19 survivours, a controlled study. Eur. J. Pain. 2021;25:1342&#x2013;1354. doi: 10.1002/ejp.1755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1755</ArticleId><ArticleId IdType="pmc">PMC8013219</ArticleId><ArticleId IdType="pubmed">33619793</ArticleId></ArticleIdList></Reference><Reference><Citation>Bileviciute-Ljungar I., Norrefalk J.R., Borg K. Pain burden in post-COVID-19 syndrome following mild COVID-19 infection. J. Clin. Med. 2022;11:771. doi: 10.3390/jcm11030771.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030771</ArticleId><ArticleId IdType="pmc">PMC8836662</ArticleId><ArticleId IdType="pubmed">35160223</ArticleId></ArticleIdList></Reference><Reference><Citation>Castaldo M., Ebbesen B.D., Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Arendt-Nielsen L., Giordano R. COVID-19 and musculoskeletal pain: An overview of the current knowledge. Minerva Anestesiol. 2023;89:1134&#x2013;1142. doi: 10.23736/S0375-9393.23.17471-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0375-9393.23.17471-2</ArticleId><ArticleId IdType="pubmed">38019176</ArticleId></ArticleIdList></Reference><Reference><Citation>Deans C., Maggert K.A. What do you mean, &#x201c;epigenetic&#x201d;? Genetics. 2015;199:887&#x2013;896. doi: 10.1534/genetics.114.173492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.114.173492</ArticleId><ArticleId IdType="pmc">PMC4391566</ArticleId><ArticleId IdType="pubmed">25855649</ArticleId></ArticleIdList></Reference><Reference><Citation>Capp J.P. Interplay between genetic, epigenetic, and gene expression variability: Considering complexity in evolvability. Evol. Appl. 2021;14:893&#x2013;901. doi: 10.1111/eva.13204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eva.13204</ArticleId><ArticleId IdType="pmc">PMC8061278</ArticleId><ArticleId IdType="pubmed">33897810</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A., Netea M.G. Trained innate immunity, epigenetics, and COVID-19. N. Engl. J. Med. 2020;383:1078&#x2013;1080. doi: 10.1056/NEJMcibr2011679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2011679</ArticleId><ArticleId IdType="pubmed">32905684</ArticleId></ArticleIdList></Reference><Reference><Citation>Behura A., Naik L., Patel S., Das M., Kumar A., Mishra A., Nayak D.K., Manna D., Mishra A., Dhiman R. Involvement of epigenetics in affecting host immunity during SARS-CoV-2 infection. Biochim. Biophys. Acta Mol. Basis Dis. 2023;1869:166634. doi: 10.1016/j.bbadis.2022.166634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2022.166634</ArticleId><ArticleId IdType="pmc">PMC9790847</ArticleId><ArticleId IdType="pubmed">36577469</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey A., Vaishak K., Deka D., Radhakrishnan A.K., Paul S., Shanmugam P., Daniel A.P., Pathak S., Duttaroy A.K., Banerjee A. Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: An updated review. Infection. 2023;51:1603&#x2013;1618. doi: 10.1007/s15010-023-02017-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-023-02017-8</ArticleId><ArticleId IdType="pmc">PMC10008189</ArticleId><ArticleId IdType="pubmed">36906872</ArticleId></ArticleIdList></Reference><Reference><Citation>Balnis J., Madrid A., Hogan K.J., Drake L.A., Chieng H.C., Tiwari A., Vincent C.E., Chopra A., Vincent P.A., Robek M.D., et al. Blood DNA Methylation and COVID-19 outcomes. Clin. Epigenetics. 2021;13:118. doi: 10.1186/s13148-021-01102-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-021-01102-9</ArticleId><ArticleId IdType="pmc">PMC8148415</ArticleId><ArticleId IdType="pubmed">34034806</ArticleId></ArticleIdList></Reference><Reference><Citation>Balnis J., Madrid A., Hogan K.J., Drake L.A., Adhikari A., Vancavage R., Singer H.A., Alisch R.S., Jaitovich A. Whole-Genome methylation sequencing reveals that COVID-19-induced epigenetic dysregulation remains 1 year after hospital discharge. Am. J. Respir. Cell Mol. Biol. 2023;68:594&#x2013;597. doi: 10.1165/rcmb.2022-0433LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2022-0433LE</ArticleId><ArticleId IdType="pmc">PMC10174161</ArticleId><ArticleId IdType="pubmed">37125894</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;ller Johansen L., Gerra M.C., Arendt-Nielsen L. Time course of DNA methylation in pain conditions: From experimental models to humans. Eur. J. Pain. 2021;25:296&#x2013;312. doi: 10.1002/ejp.1674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1674</ArticleId><ArticleId IdType="pubmed">33063322</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., D&#xed;az-Gil G., Gil-Crujera A., G&#xf3;mez-S&#xe1;nchez S.M., Ambite-Quesada S., Torres-Macho J., Ryan-Murua P., Franco-Moreno A., Pellicer-Valero O.J., Arendt-Nielsen L., et al. DNA methylation of the ACE2 promoter is not associated with post-COVID symptoms in previously hospitalized COVID-19 survivors. Microorganisms. 2024;12:1304. doi: 10.3390/microorganisms12071304.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms12071304</ArticleId><ArticleId IdType="pmc">PMC11279155</ArticleId><ArticleId IdType="pubmed">39065072</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishitani S., Parets S.E., Haas B.W., Smith A.K. DNA methylation analysis from saliva samples for epidemiological studies. Epigenetics. 2018;13:352&#x2013;362. doi: 10.1080/15592294.2018.1461295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15592294.2018.1461295</ArticleId><ArticleId IdType="pmc">PMC6140812</ArticleId><ArticleId IdType="pubmed">29912612</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare P., Raj V., Chandra S., Agarwal S. Quantitative and qualitative assessment of DNA extracted from saliva for its use in forensic identification. J. Forensic Dent. Sci. 2014;6:81&#x2013;85. doi: 10.4103/0975-1475.132529.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0975-1475.132529</ArticleId><ArticleId IdType="pmc">PMC4130022</ArticleId><ArticleId IdType="pubmed">25125913</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikeska T., Felsberg J., Hewitt C.A., Dobrovic A. Analysing DNA methylation using bisulphite pyrosequencing. Methods Mol. Biol. 2011;791:33&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">21913070</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan R., Mao S.Q., Gu T.L., Zhong F.D., Gong M.L., Hao L.M., Yin F.Y., Dong C.Z., Zhang L.N. Preliminary analysis of the association between methylation of the ACE2 promoter and essential hypertension. Mol. Med. Rep. 2017;15:3905&#x2013;3911. doi: 10.3892/mmr.2017.6460.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.6460</ArticleId><ArticleId IdType="pubmed">28440441</ArticleId></ArticleIdList></Reference><Reference><Citation>Barke A., Korwisi B., Jakob R., Konstanjsek N., Rief W., Treede R.D. Classification of chronic pain for the International Classification of Diseases (ICD-11): Results of the 2017 international World Health Organization field testing. Pain. 2022;163:e310&#x2013;e318. doi: 10.1097/j.pain.0000000000002287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002287</ArticleId><ArticleId IdType="pmc">PMC8756346</ArticleId><ArticleId IdType="pubmed">33863861</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh H.O., Choudhari R., Nema V., Khan A.A. ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease. Microb. Pathog. 2021;150:104621. doi: 10.1016/j.micpath.2020.104621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2020.104621</ArticleId><ArticleId IdType="pmc">PMC7709597</ArticleId><ArticleId IdType="pubmed">33278516</ArticleId></ArticleIdList></Reference><Reference><Citation>Faramarzi A., Safaralizadeh R., Dastmalchi N., Teimourian S. Epigenetic-related effects of COVID-19 on human cells. Infect. Disord. Drug Targets. 2022;22:21&#x2013;26. doi: 10.2174/1871526522666220420093029.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871526522666220420093029</ArticleId><ArticleId IdType="pubmed">35450534</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Pellicer-Valero O.J., Mart&#xed;n-Guerrero J.D., Hern&#xe1;ndez-Barrera V., Arendt-Nielsen L. Investigating the fluctuating nature of post-COVID pain symptoms in previously hospitalized COVID-19 survivors: The LONG-COVID-EXP multicenter study. Pain Rep. 2024;9:e1153. doi: 10.1097/PR9.0000000000001153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PR9.0000000000001153</ArticleId><ArticleId IdType="pmc">PMC11029971</ArticleId><ArticleId IdType="pubmed">38646658</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M., Del Gaudio A., Vittori A., Bimonte S., Del Prete P., Forte C.A., Cuomo A., De Blasio E. COVID-Pain: Acute and late-onset painful clinical manifestations in COVID-19: Molecular mechanisms and research perspectives. J. Pain Res. 2021;14:2403&#x2013;2412. doi: 10.2147/JPR.S313978.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S313978</ArticleId><ArticleId IdType="pmc">PMC8364364</ArticleId><ArticleId IdType="pubmed">34408485</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Rodr&#xed;guez-Jim&#xe9;nez J., Fuensalida-Novo S., Palacios-Ce&#xf1;a M., G&#xf3;mez-Mayordomo V., Florencio L.L., Hern&#xe1;ndez-Barrera V., Arendt-Nielsen L. Myalgia as a symptom at hospital admission by severe acute respiratory syndrome coronavirus 2 infection is associated with persistent musculoskeletal pain as long-term post-COVID sequelae: A case-control study. Pain. 2021;162:2832&#x2013;2840. doi: 10.1097/j.pain.0000000000002306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002306</ArticleId><ArticleId IdType="pubmed">33863864</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes D.L., Van der Feltz-Cornelis C.M., Holdsworth L., Hart S.P., O&#x2019;Halloran J., Holding S., Crooks M.G. Examining the relationship between inflammatory biomarkers during COVID-19 hospitalization and subsequent long-COVID symptoms: A longitudinal and retrospective study. Immun. Inflamm. Dis. 2023;11:e1052. doi: 10.1002/iid3.1052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.1052</ArticleId><ArticleId IdType="pmc">PMC10614127</ArticleId><ArticleId IdType="pubmed">37904690</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell J.T., Loomis A.K., Butcher L.M., Gao F., Zhang B., Hyde C.L., Sun J., Wu H., Ward K., Harris J., et al. Differential methylation of the TRPA1 promoter in pain sensitivity. Nat. Commun. 2014;5:2978. doi: 10.1038/ncomms3978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms3978</ArticleId><ArticleId IdType="pmc">PMC3926001</ArticleId><ArticleId IdType="pubmed">24496475</ArticleId></ArticleIdList></Reference><Reference><Citation>Takenaka S., Sukenaga N., Ohmuraya M., Matsuki Y., Maeda L., Takao Y., Hirose M. Association between neuropathic pain characteristics and DNA methylation of transient receptor potential ankyrin 1 in human peripheral blood. Medicine. 2020;99:e19325. doi: 10.1097/MD.0000000000019325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000019325</ArticleId><ArticleId IdType="pmc">PMC7034692</ArticleId><ArticleId IdType="pubmed">32080151</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavrilova N., Soprun L., Lukashenko M., Ryabkova V., Fedotkina T.V., Churilov L.P., Shoenfeld Y. New clinical phenotype of the Post-COVID syndrome: Fibromyalgia and joint hypermobility condition. Pathophysiology. 2022;29:24&#x2013;29. doi: 10.3390/pathophysiology29010003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathophysiology29010003</ArticleId><ArticleId IdType="pmc">PMC8954589</ArticleId><ArticleId IdType="pubmed">35366287</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Lav&#xed;n M., Miguel-&#xc1;lvarez A. Hypothetical framework for post-COVID 19 condition based on a fibromyalgia pathogenetic model. Clin. Rheumatol. 2023;42:3167&#x2013;3171. doi: 10.1007/s10067-023-06743-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-023-06743-0</ArticleId><ArticleId IdType="pubmed">37707639</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Nijs J., Neblett R., Polli A., Moens M., Goudman L., Shekhar Patil M., Knaggs R.D., Pickering G., Arendt-Nielsen L. Phenotyping post-COVID pain as a nociceptive, neuropathic, or nociplastic pain condition. Biomedicines. 2022;10:2562. doi: 10.3390/biomedicines10102562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10102562</ArticleId><ArticleId IdType="pmc">PMC9599440</ArticleId><ArticleId IdType="pubmed">36289827</ArticleId></ArticleIdList></Reference><Reference><Citation>Burri A., Marinova Z., Robinson M.D., K&#xfc;hnel B., Waldenberger M., Wahl S., Kunze S., Gieger C., Livshits G., Williams F. Are epigenetic factors implicated in chronic widespread pain? PLoS ONE. 2016;11:e0165548. doi: 10.1371/journal.pone.0165548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0165548</ArticleId><ArticleId IdType="pmc">PMC5104434</ArticleId><ArticleId IdType="pubmed">27832094</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciampi de Andrade D., Maschietto M., Galhardoni R., Gouveia G., Chile T., Victorino Krepischi A.C., Dale C.S., Brunoni A.R., Parravano D.C., Cueva Moscoso A.S., et al. Epigenetics insights into chronic pain: DNA hypomethylation in fibromyalgia: A controlled pilot-study. Pain. 2017;158:1473&#x2013;1480. doi: 10.1097/j.pain.0000000000000932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000000932</ArticleId><ArticleId IdType="pubmed">28621701</ArticleId></ArticleIdList></Reference><Reference><Citation>Fialho M.F.P., Brum E.S., Oliveira S.M. Could the fibromyalgia syndrome be triggered or enhanced by COVID-19? Inflammopharmacology. 2023;31:633&#x2013;651. doi: 10.1007/s10787-023-01160-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-023-01160-w</ArticleId><ArticleId IdType="pmc">PMC9970139</ArticleId><ArticleId IdType="pubmed">36849853</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer S., Kleinst&#xe4;uber M., Fiori L.M., Turecki G., Wagner J., von K&#xe4;nel R. DNA methylation signatures of functional somatic syndromes: Systematic review. Psychosom. Med. 2023;85:672&#x2013;681. doi: 10.1097/PSY.0000000000001237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000001237</ArticleId><ArticleId IdType="pubmed">37531610</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., de-la-Llave-Rinc&#xf3;n A.I., Ortega-Santiago R., Ambite-Quesada S., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Arias-Naval&#xf3;n J.A., Hern&#xe1;ndez-Barrera V., Mart&#xed;n-Guerrero J.D., Pellicer-Valero O.J., et al. Prevalence and risk factors of musculoskeletal pain symptoms as long-term post-COVID sequelae in hospitalized COVID-19 survivors: A multicenter study. Pain. 2022;163:e989&#x2013;e996. doi: 10.1097/j.pain.0000000000002564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002564</ArticleId><ArticleId IdType="pubmed">34913880</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmans R.S., Clauw D.J., Flint C., Harris H., Lederman S., Schrepf A. Chronic overlapping pain conditions increase the risk of long COVID features, regardless of acute COVID status. Pain. 2024;165:1112&#x2013;1120. doi: 10.1097/j.pain.0000000000003110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000003110</ArticleId><ArticleId IdType="pmc">PMC11017744</ArticleId><ArticleId IdType="pubmed">38112577</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo D., Mei B., Wang P., Li X., Chen X., Wei G., Kuang F., Li B., Su S. Prevalence and risk factors for persistent symptoms after COVID-19: A systematic review and meta-analysis. Clin. Microbiol. Infect. 2024;30:328&#x2013;335. doi: 10.1016/j.cmi.2023.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2023.10.016</ArticleId><ArticleId IdType="pubmed">37866679</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T.K.P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk factors associated with post-COVID-19 condition: A systematic review and meta-analysis. JAMA Intern. Med. 2023;183:566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Melchior M., Poisbeau P., Gaumond I., Marchand S. Insights into the mechanisms and the emergence of sex-differences in pain. Neuroscience. 2016;338:63&#x2013;80. doi: 10.1016/j.neuroscience.2016.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2016.05.007</ArticleId><ArticleId IdType="pubmed">27180284</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills S.E.E., Nicolson K.P., Smith B.H. Chronic pain: A review of its epidemiology and associated factors in population-based studies. Br. J. Anaesth. 2019;123:e273&#x2013;e283. doi: 10.1016/j.bja.2019.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.03.023</ArticleId><ArticleId IdType="pmc">PMC6676152</ArticleId><ArticleId IdType="pubmed">31079836</ArticleId></ArticleIdList></Reference><Reference><Citation>Taslem Mourosi J., Anwar S., Hosen M.J. The sex and gender dimensions of COVID-19: A narrative review of the potential underlying factors. Infect. Genet. Evol. 2022;103:105338. doi: 10.1016/j.meegid.2022.105338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2022.105338</ArticleId><ArticleId IdType="pmc">PMC9288935</ArticleId><ArticleId IdType="pubmed">35863677</ArticleId></ArticleIdList></Reference><Reference><Citation>Bwire G.M. Coronavirus: Why men are more vulnerable to COVID-19 than women? SN Compr. Clin. Med. 2020;2:874&#x2013;876. doi: 10.1007/s42399-020-00341-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00341-w</ArticleId><ArticleId IdType="pmc">PMC7271824</ArticleId><ArticleId IdType="pubmed">32838138</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>